Skip to main content

$500 Million Penalty

$500 Million Penalty,  A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in  penalties and fines for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
Federal prosecutors say the guilty plea by Ranbaxy USA Inc. represents the largest financial penalty against a generic drug company for violations of the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs.
The deal, announced Monday, concludes a years-long federal investigation into Ranbaxy's manufacturing deficiencies. The Food and Drug Administration in 2008 barred from Ranbaxy from importing more than 30 different drugs made at factories in India and, two years ago, struck a deal that required the company to ensure that data on its products is accurate, undergo extra oversight and review from a third-party and improve its drug making procedures.
The subsidiary of Ranbaxy Laboratories Limited pleaded guilty to federal criminal charges and the company separately agreed to resolve civil claims with all 50 states and the District of Columbia. The company had earlier set aside $500 million to cover potential criminal and civil liability stemming from the Justice Department investigation.
It admitted as part of the deal that it sold adulterated batches of drugs — including an antibiotic and generic versions of medications used to treat severe acne, epilepsy and nerve pain — that were developed at two manufacturing sites in India. It's not known whether the problems with the drugs led to any health issues. The problems were largely revealed by a whistleblower in a federal lawsuit filed in Maryland in 2007. The government's allegations against the company make no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.
The company admitted to a wide range of deficiencies, including improperly storing drug samples that awaiting testing, continuing to sell a medication in the U.S. even after it had failed purity tests and delaying a voluntary recall of medication that it knew would not maintain its expected its expected shelf life.
Ranbaxy also admitted making false statements to the FDA in 2006 and 2007 annual reports about dates of tests that are designed to detect drug impurities and determine appropriate storage conditions. In some cases, the tests were done weeks or months after the company said they'd been performed. Or the tests were done on the same day — or within days of each other — instead of months apart, the prescribed interval.
The company said in a written statement that it had fully cooperated with the investigation, which it said involved actions from several years ago, and expects "future growth in the U.S. and around the world with a robust pipeline of important products."
"While we are disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders; the conclusion of the DOJ investigation does not materially impact our current financial situation or performance," Ranbaxy CEO and managing director Arun Sawhney said in a statement.






$500 Million Penalty news Via abcnews
Search term: $500 Million Penalty

Comments

Popular posts from this blog

Lowongan Kerja Idaman menjadi Telemarketing

Setiap manusia yang sudah dewasa pasti membutuhkan pekerjaan. Karena tidak adanya pekerjaan manusia tidak akan bisa bertahan hidup. Manusia membutuhkan makanan minuman tempat tinggal kendaraan dan lain sebagainya yang tiu dihasilkan dari upah hasil kerja. Tanpa itu semua mnusia tidak akan bisa bertahan hidup. Ada berbagai macam pekerjaan yang bisa anda lakukan. Namun, itu semua pastinya berbeda dengan upah nya. Seperti, upah seorang pelayan restoran dan seorang dokter astilah sangat jauh berbeda. Untuk mendapatkan pekerjaan dengan upah tinggi, hal itu emerlukan kerja keras dan juga jenjang pendidikan yang tinggi. Seorang guru, dokter, pilot, perawat dan lai sebagai nya bisa melakukan pekerjaan nya dengan baik karena mereka semua melalui jalur pendidikan sejak dini hingga  dewasa. Mereka menuntut ilmu dari sejak kecil sampai dewasa dan akhirnya bisa mendapatkan posisi tersebut dengan adanya ilmu, keahlian dan kerja keras. Di era Globalisasi ini, tingkat kesadaran manusia untu...

Rob Kardashian weight loss

Rob Kardashian weight loss , The reality star not only debuted his Arthur George by Rob Kardashian sock line at Neiman Marcus in Las Vegas on May 25, but he showed off his impressive weight loss. The 26-year-old is sporting a slimmer body after recently revealing he was trying to drop the pounds he gained during his relationship with Rita Ora. "I still have to lose like 40 to 50 pounds believe it or not," Kardashian told Us Weekly at the event. "Six months, I should be there." Rob Kardashian weight loss news via Radiopatriot: weight lost Search term: Rob Kardashian weight loss

Teaching jobs

There are many benefits to studying abroad - you will acquire cross-cultural experience, gain new perspectives on your chosen field of study, and make many new friends. But studying in the United States offers additional opportunities and challenges for aspiring teachers, as the field of education is changing dramatically. Never before has so much attention been paid to the quality of teacher education and to our nation's schools. This new emphasis on teaching and learning makes it an exciting time to be working and studying in the field. For complete details about study in uk, visit abroad education corner. One reason why teacher training has become a top priority in the US is the nation's growing need for teachers. Forecasters project that we will need to hire two million new teachers over the next decade. Students who receive a teaching degree in the US will find many employment opportunities, particularly in fields like mathematics, special education, science, and ESL. F...